Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT)

PHASE3CompletedINTERVENTIONAL
Enrollment

234

Participants

Timeline

Start Date

March 31, 1990

Primary Completion Date

October 31, 1991

Study Completion Date

October 31, 1991

Conditions
HIV InfectionsCytomegalovirus Retinitis
Interventions
DRUG

Foscarnet

60 mg/kg every 8 hours, 90 mg/kg/day

DRUG

Ganciclovir

5 mg/kg every 12 hours, 5 mg/kg every 24 hours

All Listed Sponsors
collaborator

National Eye Institute (NEI)

NIH

collaborator

Johns Hopkins University

OTHER

collaborator

University of Wisconsin, Madison

OTHER

collaborator

Baylor College of Medicine

OTHER

collaborator

Louisiana State University Health Sciences Center in New Orleans

OTHER

collaborator

New York Presbyterian Hospital

OTHER

collaborator

Icahn School of Medicine at Mount Sinai

OTHER

collaborator

NYU Langone Health

OTHER

collaborator

Northwestern University

OTHER

collaborator

University of California, Los Angeles

OTHER

collaborator

University of California, San Diego

OTHER

collaborator

University of California, San Francisco

OTHER

collaborator

University of Miami

OTHER

collaborator

University of Massachusetts, Worcester

OTHER

collaborator

Memorial Sloan Kettering Cancer Center

OTHER

lead

Johns Hopkins Bloomberg School of Public Health

OTHER